Screening for NPHS2 mutations may help predict FSGS recurrence after transplantation

Journal of the American Society of Nephrology

Volumn 22, Issue 3, 2011, Pages 579-585

  Jungraithmayr, Therese C ^a   Hofer, Katrin ^a   Cochat, Pierre ^b   Chernin, Gil ^c   Cortina, Gerard ^a   Fargue, Sonja ^b   Grimm, Paul ^d   Knueppel, Tanja ^e   Kowarsch, Andreas ^f   Neuhaus, Thomas ^g   Pagel, Philipp ^f   Pfeiffer, Karl P ^h   Schäfer, Franz ^e   Schönermarck, Ulf ⁱ   Seeman, Tomas ^j   Toenshoff, Burkhard ^e   Weber, Stefanie ^e   Winn, Michelle P ^k   Zschocke, Johannes ^h   Zimmerhackl, Lothar B ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b EDOUARD HERRIOT HOSPITAL   (France)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^f TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^g UNIVERSITY OF ZURICH   (Switzerland)

^h UNIVERSITY OF INNSBRUCK   (Austria)

ⁱ LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^j The University of Econom ics Prague   (Czech Republic)

^k DUKE UNIVERSITY MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; FEMALE; FOCAL GLOMERULOSCLEROSIS; GENE; GENE MUTATION; GENETIC SCREENING; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; KIDNEY ALLOGRAFT; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NPHS2 GENE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RECURRENT DISEASE;

EID: 79952318060     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2010010029     Document Type: Article

References (22)

1. Swaminathan S, Leung N, Lager DJ, Melton LJ III, Bergstralh EJ, Rohlinger A, Fervenza FC: Changing incidence of glomerula disease in Olmsted County, Minnesota: A 30-year renal biopsy study. Clin J Am Soc Nephrol 1: 483-487, 2006
2. Tejani A, Stablein DH: Recurrence of focal segmental glomerulosclerosis posttransplantation: A special report of the North American Pediatric Renal Transplant Cooperative Study. J Am Soc Nephrol 2: 258-263, 1992
3. Cochat P, Kassir A, Colon S, Glastre C, Tourniare B, Parchoux B, Martin X, David L: Recurrent nephritic syndrome after transplantation: Early treatment with plasmaphaeresis and cyclophosphamide. Pediatr Nephrol 7: 50-54, 1993 (Pubitemid 23045337)
4. Jungraithmayr TC, Bulla M, Dippell J, Greiner C, Griebel M, Leichter HE, Plank C, Tönshoff B, Weber LT, Zimmerhackl LB; German MMF Study Group: Primary focal segmental glomerulosclerosis: Long-term outcome after pediatric renal transplantation. Pediatr Transplant 9: 226-231, 2005 (Pubitemid 40476853)
5. Hariharan S, Adams MB, Brennan DC, Davis CL, First MR, Johnson CP, Ouseph R, Peddi VR, Pelz CJ, Roza AM, Vincenti F, George V: Recurrent and de novo glomerular disease after renal transplantation: A report from Renal Allograft Disease Registry (RADR). Transplantation 68: 635-641, 1999 (Pubitemid 29453439)
6. Fine RN: Recurrence of nephrotic syndrome/focal segmental glomerulosclerosis following renal transplantation in children. Pediatr Nephrol 22: 496-502, 2007
7. Boute N, Gribouval O, Roselli S, Benessy F, Lee H, Fuchshuber A, Dahan K, Gubler MC, Niaudet P, Antignac C: NPHS2, encoding the glomerular protein podocin, is mutated in autosomal recessive steroid- resistant nephrotic syndrome. Nat Genet 24: 349-354, 2000 (Pubitemid 30187431)
8. Karle SM, Uetz B, Ronner V, Glaeser L, Hildebrandt F, Fuchshuber A: Novel mutations in NPHS2 detected in both familial and sporadic steroid-resistant nephrotic syndrome. J Am Soc Nephrol 13: 388-393, 2002 (Pubitemid 34106280)
9. Weber S, Gribouval O, Esquivel EL, Morinière V, Tête MJ, Legendre C, Niaudet P, Antignac C: NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low posttransplant recurrence. Kidney Int 66: 571-579, 2004 (Pubitemid 38981997)
10. Bertelli R, Ginevri F, Caridi G, Dagnino M, Sandrini S, Di Duca M, Emma F, Sanna-Cherchi S, Scolari F, Neri TM, Murer L, Massella L, Basile G, Rizzoni G, Perfumo F, Ghiggeri GM: Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin. Am J Kidney Dis 41: 1314-1321, 2003 (Pubitemid 36637988)
11. Caridi G, Bertelli R, Di Duca M, Dagnino M, Emma F, Onetti Muda A, Scolari F, Miglietti N, Mazzucco G, Murer L, Carrea A, Massella L, Rizzoni G, Perfumo F, Ghiggeri GM: Broadening the spectrum of diseases related to podocin mutations. J Am Soc Nephrol 14: 1278-1286, 2003 (Pubitemid 36519196)
12. Caridi G, Perfumo F, Ghiggeri GM: NPHS2 (Podocin) mutations in nephrotic syndrome. Clinical spectrum and fine mechanisms. Pediatr Res 57: 54R-61R, 2005
13. Tsukaguchi H, Sudhakar A, Le TC, Nguyen T, Yao J, Schwimmer JA, Schachter AD, Poch E, Abreu PF, Appel GB, Pereira AB, Kalluri R, Pollak MR: NPHS2 mutations in late-onset focal segmental glomerulosclerosis: R229Q is a common disease-associated allele. J Clin Invest 110: 1659-1666, 2002 (Pubitemid 35424244)
14. Pereira AC, Pereira AB, Mota GF, Cunha RS, Herkenhoff FL, Pollak MR, Mill JG, Krieger JE: NPHS2 R229Q functional variant is associated with microalbuminuria in the general population. Kidney Int 65: 1026-1030, 2004 (Pubitemid 38258280)
15. Newstead CG: Recurrent disease in renal transplants. Nephrol Dial Transplant 18[Suppl 6]: 68-74, 2003
16. Pardon A, Audard V, Caillard S, Moulin B, Desvaux D, Bentaarit B, Remy P, Sahali D, Roudot-Thoraval F, Lang P, Grimbert P: Risk factors and outcome of focal and segmental glomerulosclerosis recurrence in adult renal transplant recipients. Nephrol Dial Transplant 21: 1053-1059, 2006
17. Pinto J, Lacerda G, Cameron JS, Turner DR, Bewick M, Ogg CS: Recurrence of focal segmental glomerulosclerosis in renal allografts. Transplantation 32: 83-89, 1981 (Pubitemid 11046905)
18. Stephanian E, Matas AJ, Mauer SM, Chavers B, Nevins T, Kashtan C, Sutherland DE, Gores P, Najarian JS: Recurrence of disease in patients retransplanted for focal segmental glomerulosclerosis. Transplantation 53: 755-757, 1992
19. Ruf RG, Lichtenberger A, Karle SM, Haas JP, Anacleto FE, Schultheiss M, Zalewski I, Imm A, Ruf EM, Mucha B, Bagga A, Neuhaus T, Fuchshuber A, Bakkaloglu A, Hildebrandt F; Arbeitsgemeinschaft Für Pädiatrische Nephrologie Study Group: Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome. J Am Soc Nephrol 15: 722-732, 2004 (Pubitemid 38294803)
20. Baum MA, Stablein DM, Panzarino VM, Tejani A, Harmon WE, Alexander SR: Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis. Kidney Int 59: 328-333, 2001 (Pubitemid 32055241)
21. Winn MP, Conlon PJ, Lynn KL, Farrington MK, Creazzo T, Hawkins AF, Daskalakis N, Kwan SY, Ebersviller S, Burchette JL, Pericak-Vance MA, Howell DN, Vance JM, Rosenberg PB: A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosis. Science 308: 1801-1804, 2005
22. Racusen LC, Solez K, Colvin RB, Bonsib SM, Castro MC, Cavallo T, Croker BP, Demetris AJ, Drachenberg CB, Fogo AB, Furness P, Gaber LW, Gibson IW, Glotz D, Goldberg JC, Grande J, Halloran PF, Hansen HE, Hartley B, Hayry PJ, Hill CM, Hoffman EO, Hunsicker LG, Lindblad AS, Yamaguchi Y, et al.: The Banff 97 working classification of renal allograft pathology. Kidney Int 55: 713-723, 1999 (Pubitemid 29082898)